Acro Biomedical Co., Ltd. (ACBM)

Acro Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2	1	0	6	270	279
Market Cap Growth	-99.33%	3071.46%	-99.33%	-97.67%	-3.23%	101.58%
Enterprise Value	2	2	0	6	270	279
Last Close Price	0.03	0.02	0.00	0.10	4.50	4.65
PS Ratio	-	-	-	-	410.31	233.15
PB Ratio	-4.03	-3.44	-0.14	-24.53	555.52	433.73
P/TBV Ratio	-	-	-	-	555.52	433.73
P/OCF Ratio	-	-	-	-	-	932.72
EV/Sales Ratio	-	-	-	-	410.45	233.04
Debt / Equity Ratio	-0.84	-0.84	-0.52	-0.55	0.22	0.11
Net Debt / Equity Ratio	-0.83	-0.83	-0.51	-0.55	0.20	-0.04
Asset Turnover	-	-	-	-	0.91	1.36
Inventory Turnover	-	-	-	-	43.17	1.95
Quick Ratio	0.01	0.01	0.00	0.00	3.20	7.56
Current Ratio	0.04	0.04	0.02	0.01	3.27	7.71
Return on Equity (ROE)	-	-	-	-7680.26%	-2808.92%	-1157.94%
Return on Assets (ROA)	-417.89%	-417.89%	-52.47%	-1473.36%	-1369.44%	-546.69%
Return on Invested Capital (ROIC)	-	-	-	-3751.79%	-2634.65%	-989.64%
Return on Capital Employed (ROCE)	39.80%	39.80%	12.90%	3820.80%	-3262.90%	-1149.30%
Earnings Yield	-6.48%	-7.59%	-100.64%	-139.70%	-5.87%	-2.76%
Buyback Yield / Dilution	-	-	-	-	-11.52%	-12.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.